Experimental infection of Egyptian rousette bats (Rousettus aegyptiacus) with Sosuga virus demonstrates potential transmission routes for a bat-borne human pathogenic paramyxovirus

In August 2012, a wildlife biologist became severely ill after becoming infected with a novel paramyxovirus, termed Sosuga virus. In the weeks prior to illness, the patient worked with multiple species of bats in South Sudan and Uganda, including Egyptian rousette bats (ERBs: Rousettus aegyptiacus). A follow-up study of Ugandan bats found multiple wild-caught ERBs to test positive for SOSV in liver and spleen. To determine the competency of these bats to act as a natural reservoir host for SOSV capable of infecting humans, captive-bred ERBs were inoculated with a recombinant SOSV, representative of the patient's virus sequence. The bats were inoculated subcutaneously, sampled daily (blood, urine, fecal, oral and rectal swabs) and serially euthanized at predetermined time points. All inoculated bats became infected with SOSV in multiple tissues and blood, urine, oral, rectal and fecal swabs tested positive for SOSV RNA. No evidence of overt morbidity or mortality were observed in infected ERBs, although histopathological examination showed subclinical disease in a subset of tissues. Importantly, SOSV was isolated from oral/rectal swabs, urine and feces, demonstrating shedding of infectious virus concomitant with systemic infection. All bats euthanized at 21 days post-inoculation (DPI) seroconverted to SOSV between 16 and 21 DPI. These results are consistent with ERBs being competent reservoir hosts for SOSV with spillover potential to humans. Author summary Sosuga virus (SOSV) was first identified in August 2012 in a sample obtained from a biologist that had become severely ill after working with bats in Sudan and Uganda. Testing of bat tissues from Uganda revealed the presence of SOSV RNA in Egyptian rousette bats (ERB: Rousettus aegyptiacus). To more definitively determine if these bats could be reservoir hosts of SOSV with potential for transmitting the virus to humans, we subcutaneously inoculated 12 captive-bred ERBs with a recombinant SOSV and collected biological samples daily through 21 days post inoculation (DPI) to investigate the dynamics of virus infection and shedding. All bats became infected with SOSV and exhibited only mild cellular pathology following histopathological analyses. Multiple qRT-PCR and virus isolation positive tissues were collected as well as urine, oral, rectal, and fecal swabs, indicative of a systemic infection. At study completion, no animals had displayed any overt clinical signs of infection, virus was detected in multiple tissues, and all infected bats euthanized at the latest time point had seroconverted to SOSV. Collectively, our study demonstrates ERBs are a competent host and exhibit attributes consistent with being a natural reservoir and zoonotic source for SOSV.